Review



3 homology arm  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Addgene inc 3 homology arm
    3 Homology Arm, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 29 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3+homology+arm/pmc12638043-197-34-55?v=Addgene+inc
    Average 93 stars, based on 29 article reviews
    3 homology arm - by Bioz Stars, 2026-07
    93/100 stars

    Images



    Similar Products

    95
    New England Biolabs annealed homology arm 0 5
    Annealed Homology Arm 0 5, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3+homology+arm/us12305168-462-150-159?v=New+England+Biolabs
    Average 95 stars, based on 1 article reviews
    annealed homology arm 0 5 - by Bioz Stars, 2026-07
    95/100 stars
      Buy from Supplier

    93
    Addgene inc 3 homology arm
    3 Homology Arm, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3+homology+arm/pmc12638043-197-34-55?v=Addgene+inc
    Average 93 stars, based on 1 article reviews
    3 homology arm - by Bioz Stars, 2026-07
    93/100 stars
      Buy from Supplier

    90
    Twist Bioscience dna fragments for the 5′ and 3′ homology arms of npm1, hp1α, srrm2, ewsr1 and fus
    Dna Fragments For The 5′ And 3′ Homology Arms Of Npm1, Hp1α, Srrm2, Ewsr1 And Fus, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3+homology+arm/pm40468084-593-15-19?v=Twist+Bioscience
    Average 90 stars, based on 1 article reviews
    dna fragments for the 5′ and 3′ homology arms of npm1, hp1α, srrm2, ewsr1 and fus - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Thermo Fisher 5’ homology arm-linkermaid-3’utr fragment
    5’ Homology Arm Linkermaid 3’utr Fragment, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3+homology+arm/pm39880081-194-2-9?v=Thermo+Fisher
    Average 90 stars, based on 1 article reviews
    5’ homology arm-linkermaid-3’utr fragment - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Biomatik donor dna construct containing homologous arms and loxp sites around ccr7 exon 3
    Donor Dna Construct Containing Homologous Arms And Loxp Sites Around Ccr7 Exon 3, supplied by Biomatik, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3+homology+arm/pmc11588065-187-36-42?v=Biomatik
    Average 90 stars, based on 1 article reviews
    donor dna construct containing homologous arms and loxp sites around ccr7 exon 3 - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    99
    New England Biolabs kb 3 homologous arm
    Kb 3 Homologous Arm, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3+homology+arm/pmc11629738-259-29-36?v=New+England+Biolabs
    Average 99 stars, based on 1 article reviews
    kb 3 homologous arm - by Bioz Stars, 2026-07
    99/100 stars
      Buy from Supplier

    90
    Twist Bioscience dnaencoding the 5′ and 3′ homology arms of wrn
    Dnaencoding The 5′ And 3′ Homology Arms Of Wrn, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3+homology+arm/pm37932011-172-7-20?v=Twist+Bioscience
    Average 90 stars, based on 1 article reviews
    dnaencoding the 5′ and 3′ homology arms of wrn - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Sangon Biotech 2-kb 3′ homologous arm sequence including the g.c-to-a.t point mutation
    2 Kb 3′ Homologous Arm Sequence Including The G.C To A.T Point Mutation, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3+homology+arm/pm37864194-228-8-14?v=Sangon+Biotech
    Average 90 stars, based on 1 article reviews
    2-kb 3′ homologous arm sequence including the g.c-to-a.t point mutation - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Sangon Biotech 2-kb 3′ homologous arm sequence
    2 Kb 3′ Homologous Arm Sequence, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3+homology+arm/pm37864194-229-2-14?v=Sangon+Biotech
    Average 90 stars, based on 1 article reviews
    2-kb 3′ homologous arm sequence - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    90
    Twist Bioscience dna encoding the 5’- and 3’-homology arms of wrn
    (A-B) Immunoblotting depicting the rapid induction of pKAP1, a marker <t>of</t> <t>DNA</t> double strand breaks, by 0.5 μM dTAG-13 in RKO (A) and KM12 (B) clones expressing <t>FKBP-WRN.</t> By contrast, dTAG-13 did not induce pKAP1 in OVCAR8 clones expressing FKBP-WRN even after extended treatment. One of two independent experiments is shown. (C) END-seq showing the rapid appearance of DNA breakage at unstable expanded TA repeats in KM12 cells treated with 0.5 μM dTAG-13. (D) Upper panel, immunoblotting showing that 0.5 μM dTAG-13 (24 h) induced significantly lower levels of pKAP1 in RKO and KM12 cells pre-treated for 24 h with 5 μM Palbociclib (PLB). Lower panel, successful inhibition of S-phase entry by PLB was confirmed by FACS-based cell cycle analyses. One of three independent experiments is shown. (E) Immunoblotting demonstrating the lack of CHK1 (S317) and RPA2 (S33) phosphorylation in dTAG-treated RKO FKBP-WRN cells. CHK1/RPA2 phosphorylation was also undetectable in KM12 FKBP-WRN cells except at 24 h after dTAG-13 treatment. Where indicated, cells were treated with 3 mM hydroxyurea (HU) for 2 h, either alone or in combination with 0.5 μM dTAG-13 (2 h dTAG-13 pre-treatment followed by 2 h HU+dTAG-13). Note that HU induced robust CHK1/RPA phosphorylation in both RKO and KM12 independently of WRN. One of two independent experiments is shown. (F) FACS-based cell cycle analyses showing that dTAG-treated RKO and KM12 cells failed to slow down or halt DNA synthesis during the first S-phase after acute WRN degradation. Note that WRN-degraded cells eventually completed S-phase and activated the G2 checkpoint. (G) Representative confocal images depicting RAD51 foci (maximum intensity projection) in RKO FKBP-WRN cells treated or not with 0.5 μM dTAG-13 for 24 h. Cyclin A (CCNA) and EdU positivity were used to distinguish cells in S-phase from those in G2. Note that RAD51 foci appear to be larger in G2 cells (EdU-negative, CCNA-high), as compared to S-phase cells (EdU-positive, CCNA-low/intermediate). (H) Quantification of RAD51 number per nucleus as a function of cell cycle position. (I) Volumetric analysis of RAD51 foci as a function of cell cycle position. One of two independent experiment is shown.
    Dna Encoding The 5’ And 3’ Homology Arms Of Wrn, supplied by Twist Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/3+homology+arm/pmc10473727-568-8-12?v=Twist+Bioscience
    Average 90 stars, based on 1 article reviews
    dna encoding the 5’- and 3’-homology arms of wrn - by Bioz Stars, 2026-07
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A-B) Immunoblotting depicting the rapid induction of pKAP1, a marker of DNA double strand breaks, by 0.5 μM dTAG-13 in RKO (A) and KM12 (B) clones expressing FKBP-WRN. By contrast, dTAG-13 did not induce pKAP1 in OVCAR8 clones expressing FKBP-WRN even after extended treatment. One of two independent experiments is shown. (C) END-seq showing the rapid appearance of DNA breakage at unstable expanded TA repeats in KM12 cells treated with 0.5 μM dTAG-13. (D) Upper panel, immunoblotting showing that 0.5 μM dTAG-13 (24 h) induced significantly lower levels of pKAP1 in RKO and KM12 cells pre-treated for 24 h with 5 μM Palbociclib (PLB). Lower panel, successful inhibition of S-phase entry by PLB was confirmed by FACS-based cell cycle analyses. One of three independent experiments is shown. (E) Immunoblotting demonstrating the lack of CHK1 (S317) and RPA2 (S33) phosphorylation in dTAG-treated RKO FKBP-WRN cells. CHK1/RPA2 phosphorylation was also undetectable in KM12 FKBP-WRN cells except at 24 h after dTAG-13 treatment. Where indicated, cells were treated with 3 mM hydroxyurea (HU) for 2 h, either alone or in combination with 0.5 μM dTAG-13 (2 h dTAG-13 pre-treatment followed by 2 h HU+dTAG-13). Note that HU induced robust CHK1/RPA phosphorylation in both RKO and KM12 independently of WRN. One of two independent experiments is shown. (F) FACS-based cell cycle analyses showing that dTAG-treated RKO and KM12 cells failed to slow down or halt DNA synthesis during the first S-phase after acute WRN degradation. Note that WRN-degraded cells eventually completed S-phase and activated the G2 checkpoint. (G) Representative confocal images depicting RAD51 foci (maximum intensity projection) in RKO FKBP-WRN cells treated or not with 0.5 μM dTAG-13 for 24 h. Cyclin A (CCNA) and EdU positivity were used to distinguish cells in S-phase from those in G2. Note that RAD51 foci appear to be larger in G2 cells (EdU-negative, CCNA-high), as compared to S-phase cells (EdU-positive, CCNA-low/intermediate). (H) Quantification of RAD51 number per nucleus as a function of cell cycle position. (I) Volumetric analysis of RAD51 foci as a function of cell cycle position. One of two independent experiment is shown.

    Journal: bioRxiv

    Article Title: Comprehensive mapping of cell fates in microsatellite unstable cancer cells support dual targeting of WRN and ATR

    doi: 10.1101/2023.07.28.550976

    Figure Lengend Snippet: (A-B) Immunoblotting depicting the rapid induction of pKAP1, a marker of DNA double strand breaks, by 0.5 μM dTAG-13 in RKO (A) and KM12 (B) clones expressing FKBP-WRN. By contrast, dTAG-13 did not induce pKAP1 in OVCAR8 clones expressing FKBP-WRN even after extended treatment. One of two independent experiments is shown. (C) END-seq showing the rapid appearance of DNA breakage at unstable expanded TA repeats in KM12 cells treated with 0.5 μM dTAG-13. (D) Upper panel, immunoblotting showing that 0.5 μM dTAG-13 (24 h) induced significantly lower levels of pKAP1 in RKO and KM12 cells pre-treated for 24 h with 5 μM Palbociclib (PLB). Lower panel, successful inhibition of S-phase entry by PLB was confirmed by FACS-based cell cycle analyses. One of three independent experiments is shown. (E) Immunoblotting demonstrating the lack of CHK1 (S317) and RPA2 (S33) phosphorylation in dTAG-treated RKO FKBP-WRN cells. CHK1/RPA2 phosphorylation was also undetectable in KM12 FKBP-WRN cells except at 24 h after dTAG-13 treatment. Where indicated, cells were treated with 3 mM hydroxyurea (HU) for 2 h, either alone or in combination with 0.5 μM dTAG-13 (2 h dTAG-13 pre-treatment followed by 2 h HU+dTAG-13). Note that HU induced robust CHK1/RPA phosphorylation in both RKO and KM12 independently of WRN. One of two independent experiments is shown. (F) FACS-based cell cycle analyses showing that dTAG-treated RKO and KM12 cells failed to slow down or halt DNA synthesis during the first S-phase after acute WRN degradation. Note that WRN-degraded cells eventually completed S-phase and activated the G2 checkpoint. (G) Representative confocal images depicting RAD51 foci (maximum intensity projection) in RKO FKBP-WRN cells treated or not with 0.5 μM dTAG-13 for 24 h. Cyclin A (CCNA) and EdU positivity were used to distinguish cells in S-phase from those in G2. Note that RAD51 foci appear to be larger in G2 cells (EdU-negative, CCNA-high), as compared to S-phase cells (EdU-positive, CCNA-low/intermediate). (H) Quantification of RAD51 number per nucleus as a function of cell cycle position. (I) Volumetric analysis of RAD51 foci as a function of cell cycle position. One of two independent experiment is shown.

    Article Snippet: DNA encoding the 5’- and 3’-homology arms of WRN was obtained from Twist Biosciences and subsequently cloned into pGMC00018, along with the PCR product encoding Puromycin R -2A-3X-FLAG-FKBP12 or eGFP-2A-3X-FLAG-FKBP12, using isothermal assembly.

    Techniques: Western Blot, Marker, Clone Assay, Expressing, Inhibition, Phospho-proteomics, DNA Synthesis

    (A) Schematics of the RKO triple reporter line used for live cell imaging. An example of a vehicle-treated cells is shown below in the CFP, RFP and YFP channels. (B) Automated cell tracking was performed as described in the Methods section. Example traces of a vehicle-treated reporter cell over time; different phases of a cell cycle are indicated. The birth of a cell at mitosis (M) coincides with a reduction in nuclear area (as defined by H2B-mTurquoise) as well as PIP sensor intensity. PIP intensity increases in G1 but is then abruptly lost as a cell enters S-phase. Finally, PIP expression returns in G2. 53BP1 foci formation is also shown for this vehicle-treated cell. (C) Formation of 53BP1 puncta as a function of time. Cells were first imaged for approximately 20 h without drug to establish baseline 53BP1 levels. Subsequent addition of dTAG-13 resulted in a rapid induction of 53BP1 puncta over the baseline, which steadily increased over time. One of two independent experiments is shown. (D) Example traces of four dTAG-treated reporter cells. The two cells on the left panels showed induction of 53BP1 puncta during the first S-phase after WRN degradation. The two cells on the right panels had primarily induced 53BP1 in the first G2 after WRN degradation. Note however that these two cells also displayed a smaller induction of 53BP1 in the preceding S-phase. (E) Quantification of 53BP1 puncta intensity during the first cell cycle following acute WRN degradation revealed that peak 53BP1 induction occur predominantly in S and G2. One of two independent experiments is shown. (F) Analyses of metaphase spreads showed that a majority of dTAG-treated RKO cells failed to completely repair DNA breaks incurred in S/G2 and carried residual damages into the first mitosis. One of two independent experiments is shown.

    Journal: bioRxiv

    Article Title: Comprehensive mapping of cell fates in microsatellite unstable cancer cells support dual targeting of WRN and ATR

    doi: 10.1101/2023.07.28.550976

    Figure Lengend Snippet: (A) Schematics of the RKO triple reporter line used for live cell imaging. An example of a vehicle-treated cells is shown below in the CFP, RFP and YFP channels. (B) Automated cell tracking was performed as described in the Methods section. Example traces of a vehicle-treated reporter cell over time; different phases of a cell cycle are indicated. The birth of a cell at mitosis (M) coincides with a reduction in nuclear area (as defined by H2B-mTurquoise) as well as PIP sensor intensity. PIP intensity increases in G1 but is then abruptly lost as a cell enters S-phase. Finally, PIP expression returns in G2. 53BP1 foci formation is also shown for this vehicle-treated cell. (C) Formation of 53BP1 puncta as a function of time. Cells were first imaged for approximately 20 h without drug to establish baseline 53BP1 levels. Subsequent addition of dTAG-13 resulted in a rapid induction of 53BP1 puncta over the baseline, which steadily increased over time. One of two independent experiments is shown. (D) Example traces of four dTAG-treated reporter cells. The two cells on the left panels showed induction of 53BP1 puncta during the first S-phase after WRN degradation. The two cells on the right panels had primarily induced 53BP1 in the first G2 after WRN degradation. Note however that these two cells also displayed a smaller induction of 53BP1 in the preceding S-phase. (E) Quantification of 53BP1 puncta intensity during the first cell cycle following acute WRN degradation revealed that peak 53BP1 induction occur predominantly in S and G2. One of two independent experiments is shown. (F) Analyses of metaphase spreads showed that a majority of dTAG-treated RKO cells failed to completely repair DNA breaks incurred in S/G2 and carried residual damages into the first mitosis. One of two independent experiments is shown.

    Article Snippet: DNA encoding the 5’- and 3’-homology arms of WRN was obtained from Twist Biosciences and subsequently cloned into pGMC00018, along with the PCR product encoding Puromycin R -2A-3X-FLAG-FKBP12 or eGFP-2A-3X-FLAG-FKBP12, using isothermal assembly.

    Techniques: Live Cell Imaging, Cell Tracking Assay, Expressing